Elucidating the specific pharmacological mechanism of action (MOA) of Obviously occurring compounds could be complicated. Although Tarselli et al. (sixty) formulated the 1st de novo synthetic pathway to conolidine and showcased that this naturally happening compound correctly suppresses responses to